Stock picks from our team of market veterans.
Today I’m putting last Saturday’s star performing stocks under the analysts’ microscope to see if the gains are a sign of better returns to come. Three out of four of these look very interesting.
Last week, three of the major banks reported full year profit results (CBA will provide a third quarter trading update on Wednesday). Here’s a review of what we learnt and my position in relation to the question about how to play the banks going forward.
In the week ending Friday, May 9, 2025, FNArena tracked five upgrades and 12 downgrades for ASX-listed companies from brokers monitored daily.
In a very volatile April, our model portfolios finished higher. Our income portfolio continues to outperform.
In a very busy week of quarterly reporting ending on Friday 2 May 2025, FNArena tracked nine upgrades and nine downgrades for ASX-listed companies from brokers monitored daily.
Anecdotal evidence from many tourism operators points to Aussie travellers rethinking travel plans to travel at home – where the Australian dollar will always be an Australian dollar. Here are two potential exposures that analysts think represent good value.
For the three business days ending Thursday 24 April 2025, FNArena tracked five upgrades and just the one downgrade for ASX-listed companies from brokers monitored daily.
While this precious metal rally may have further to run, some profit-taking is prudent, but hear me out why I say this.
The outlook for CSL (one of the few true global leaders on the ASX) from the analysts (who aren’t always right) is that the recent price decline gives investors an improved access point to a high-quality global healthcare exposure. Let’s put CSL under the microscope.
For the week ended Friday 11 April 2025, FNArena tracked 15 upgrades and 13 downgrades for ASX-listed companies from brokers monitored daily.
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.